BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 324754)

  • 1. Effects of hypothalamic factors on insulin and glucagon release from the islets of Langerhans.
    Moltz JH; Dobbs RE; McCann SM; Fawcett CP
    Endocrinology; 1977 Jul; 101(1):196-202. PubMed ID: 324754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets.
    Dolais-Kitabgi J; Kitabgi P; Brazeau P; Freychet P
    Endocrinology; 1979 Jul; 105(1):256-60. PubMed ID: 376297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas.
    Goto Y; Carpenter RG; Berelowitz M; Frohman LA
    Metabolism; 1980 Oct; 29(10):986-90. PubMed ID: 6106879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat.
    Rohner-Jeanrenaud F; Jeanrenaud B
    J Clin Invest; 1980 Apr; 65(4):902-10. PubMed ID: 6987269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothalamo-pancreatic axis: evidence for a neurohormonal pathway in the control of the release of insulin and glucagon.
    Moltz JH; Fawcett CP; McCann SM
    Endocr Res Commun; 1975; 2(8):537-47. PubMed ID: 1222722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats.
    Seino Y; Seino S; Takemura J; Tsuda K; Nishi S; Ishida H; Seno M; Usami M; Ikeda M; Imura H
    Endocrinology; 1984 Feb; 114(2):457-61. PubMed ID: 6140160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats.
    Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1981 Mar; 20(3):217-22. PubMed ID: 6112185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of norepinephrine on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets.
    Sorenson RL; Elde RP; Seybold V
    Diabetes; 1979 Oct; 28(10):899-904. PubMed ID: 383555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic regulation of insulin release in rhesus monkeys.
    Hill DE; Mayes S; DiBattista D; Lockhart-Ewart R; Martin JM
    Diabetes; 1977 Aug; 26(8):726-31. PubMed ID: 407117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; HÃ¥kanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin inhibits glucose but not glucagon-induced insulin and somatostatin release in isolated islets.
    Dolais-Kitabgi J; Freychet P
    Diabete Metab; 1979 Dec; 5(4):275-7. PubMed ID: 44873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J; Schatz H; Nierle C; Pfeiffer EF
    Horm Metab Res; 1975 Jul; 7(4):284-7. PubMed ID: 168138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histaminergic mechanism of neurotensin-induced glucagon release from isolated rat pancreatic islets.
    Itatsu T; Shibata A; Ukai M
    Endocrinol Jpn; 1981 Oct; 28(5):631-5. PubMed ID: 7047156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neurotensin and substance P on insulin and glucagon release by the perfused dog pancreas [proceedings].
    Patton G; Brown M; Dobbs R; Vale W; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1465. PubMed ID: 790094
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and properties of hypothalamic factors capable of altering pancreatic hormone release in vitro.
    Moltz JH; Dobbs RE; McCann SM; Fawcett CP
    Endocrinology; 1979 Nov; 105(5):1262-8. PubMed ID: 385304
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuronal influence on hormone release from anglerfish islet cells.
    Milgram SL; McDonald JK; Noe BD
    Am J Physiol; 1991 Oct; 261(4 Pt 1):E444-56. PubMed ID: 1681734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187.
    Fujimoto WY; Ensinck JW
    Endocrinology; 1976 Jan; 98(1):259-62. PubMed ID: 765117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dissociation and culture on the maintenance of insulin, glucagon and somatostatin release by neonatal rat islets of Langerhans.
    Schwizer RW
    Life Sci; 1984 Aug; 35(7):783-8. PubMed ID: 6147743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.